Literature DB >> 30024741

Lys-C/Arg-C, a More Specific and Efficient Digestion Approach for Proteomics Studies.

Zhen Wu1, Jichang Huang1, Jingnan Huang1, Qingqing Li1, Xumin Zhang1.   

Abstract

Nowadays, bottom-up approaches are predominantly adopted in proteomics studies, which necessitate a proteolysis step prior to MS analysis. Trypsin is often the best protease in choice due to its high specificity and MS-favored proteolytic products. A lot of efforts have been made to develop a superior digestion approach but hardly succeed, especially in large-scale proteomics studies. Herein, we report a new tandem digestion using Lys-C and Arg-C, termed Lys-C/Arg-C, which has been proven to be more specific and efficient than trypsin digestion. Reanalysis of our previous data ( Anal. Chem. 2018, 90 (3), 1554-1559) revealed that both Lys-C and Arg-C are trypsin-like proteases and perform better when considered as trypsin. In particular, for Arg-C, the identification capacity is increased to 2.6 times and even comparable with trypsin. The good complementarity, high digestion efficiency, and high specificity of Lys-C and Arg-C prompt the Lys-C/Arg-C digestion. We systematically evaluated Lys-C/Arg-C digestion using qualitative and quantitative proteomics approaches and confirmed its superior performance in digestion specificity, efficiency, and identification capacity to the currently widely used trypsin and Lys-C/trypsin digestions. As a result, we concluded that the Lys-C/Arg-C digestion approach would be the choice of next-generation digestion approach in both qualitative and quantitative proteomics studies. Data are available via ProteomeXchange with identifier PXD009797.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30024741     DOI: 10.1021/acs.analchem.8b02448

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  7 in total

1.  Immunopeptidomic Analysis Reveals That Deamidated HLA-bound Peptides Arise Predominantly from Deglycosylated Precursors.

Authors:  Shutao Mei; Rochelle Ayala; Sri H Ramarathinam; Patricia T Illing; Pouya Faridi; Jiangning Song; Anthony W Purcell; Nathan P Croft
Journal:  Mol Cell Proteomics       Date:  2020-05-01       Impact factor: 5.911

2.  A Protocol for Isolation, Purification, Characterization, and Functional Dissection of Exosomes.

Authors:  Alin Rai; Haoyun Fang; Monique Fatmous; Bethany Claridge; Qi Hui Poh; Richard J Simpson; David W Greening
Journal:  Methods Mol Biol       Date:  2021

3.  Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma.

Authors:  Antonia Reale; Tiffany Khong; Rong Xu; Maoshan Chen; Sridurga Mithraprabhu; Nicholas Bingham; Andrew Spencer; David W Greening
Journal:  Methods Mol Biol       Date:  2021

4.  Spliceosome disassembly factors ILP1 and NTR1 promote miRNA biogenesis in Arabidopsis thaliana.

Authors:  Junli Wang; Susu Chen; Ning Jiang; Ning Li; Xiaoyan Wang; Zhongpeng Li; Xu Li; Hongtao Liu; Lin Li; Yu Yang; Ting Ni; Chaoyi Yu; Jinbiao Ma; Binglian Zheng; Guodong Ren
Journal:  Nucleic Acids Res       Date:  2019-09-05       Impact factor: 16.971

5.  Optimization of Synovial Fluid Collection and Processing for NMR Metabolomics and LC-MS/MS Proteomics.

Authors:  James R Anderson; Marie M Phelan; Luis M Rubio-Martinez; Matthew M Fitzgerald; Simon W Jones; Peter D Clegg; Mandy J Peffers
Journal:  J Proteome Res       Date:  2020-04-07       Impact factor: 4.466

6.  In-depth characterization and comparison of the N-glycosylated proteome of two-dimensional- and three-dimensional-cultured breast cancer cells and xenografted tumors.

Authors:  Yonghong Mao; Yang Zhao; Yong Zhang; Hao Yang
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

7.  Targeting proline in (phospho)proteomics.

Authors:  Saar A M van der Laarse; Charlotte A G H van Gelder; Marshall Bern; Michiel Akeroyd; Maurien M A Olsthoorn; Albert J R Heck
Journal:  FEBS J       Date:  2020-01-13       Impact factor: 5.542

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.